| Novartis Pharma Schweiz AG - Tasigna 200 mg, Kapseln | | 58007 | | 01 | | Tasigna 200 mg | | Kapseln | | L01EA03 | | Nilotinib | | 24.07.2007 | | |
| | Composition | | nilotinibum 200 mg ut nilotinibi hydrochloridum monohydricum, lactosum monohydricum 156.11 mg, crospovidonum, poloxamerum 188, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (flavum), Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, E 172 (rubrum), pro capsula. | | Packungsbestandteile | | Capsules | | | | | Active Agent | Dose |
|---|
| Nilotinibum | 200 mg |
| | BAG: Active Agent | Dose |
|---|
| Nilotinibum | 200 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | (Rubrum) | | | | Ammoniae Solutio Concentrata | | | | Crospovidonum | | | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Lactose Monohydrate | 156.11 mg | | | Magnesii Stearas | | | | Poloxamer | 188 | | | Pro Capsula | | | | Propylenglycol | | | | Silica Colloidalis Anhydrica | | |
| |
| |
|
